Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
04/1997
04/16/1997EP0768312A2 Bis-Staurosporine and K-252a derivatives
04/16/1997EP0768306A1 Physiologically active hydrogenated benzopyran compounds
04/16/1997EP0768305A1 N-Isoxazolyl-biphenylsulfonamide derivatives, their preparation and their use as endothelin antagonists
04/16/1997EP0768304A1 N-(Pyrimidinyl)-benzenesulfonamides as medicaments
04/16/1997EP0768089A1 Health composition
04/16/1997EP0768083A2 The use of sertraline to treat post myocardial infarction patients
04/16/1997EP0767801A1 Endothelin antagonists ii
04/16/1997EP0767800A1 Histidine and homohistidine derivatives as inhibitors of protein farnesyltransferase
04/16/1997EP0767796A1 Monocyte chemotactic protein-4
04/16/1997EP0767794A1 Phosphinic acid derivatives
04/16/1997EP0767792A1 Vitronectin receptor antagonists
04/16/1997EP0767787A1 (3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants
04/16/1997EP0767782A1 Aryl and heteroaryl alkoxynaphthalene derivatives
04/16/1997EP0767675A1 The use of cross-linked hemoglobin in treating subarachnoid hemorrhage
04/16/1997EP0767674A1 Process to inhibit binding of the integrin alpha 4 beta 1 to vcam-1 or fibronectin
04/16/1997EP0701551B1 3-(indol-3-yl) propenoic acid derivatives useful as nmda antagonists
04/16/1997EP0656780B1 Drugs containing diphosphonic acids and salts thereof
04/16/1997CN1147767A Use of serotonin antagonists (5HT3) for treating fibromyalgia
04/16/1997CN1147765A Remedy for pulmonary heart
04/16/1997CN1147520A 11-(substituted phenyl)-estra-4,9-diene derivatives
04/16/1997CN1147512A Substituted 4H-pyrans
04/16/1997CN1147506A Benzoazepine-Benzooxaazepine-Benzothiaazepine-N-acetate derivant
04/16/1997CN1147406A Cockscomb beverage
04/16/1997CN1147401A Medicine for heart disease
04/16/1997CN1034575C Producing process for selective adenosine receptor agents
04/16/1997CN1034569C Endothelin receptor antagonists
04/15/1997US5621113 4-[(thien-2-yl)methyl]-imidazole analgesics
04/15/1997US5621102 Reacting pinanediol chiral director and haloalkyl dialkoxy metalloid compound to undergo homologation reaction to form intermediate, reacting it with grignard reagent to form secondary alchol, acylating, coupling side chain
04/15/1997US5621098 Process for preparing bis-indolyl macrocycles
04/15/1997US5620998 Cardiovascular disorders; hypotensive agents
04/15/1997US5620997 Viricides, antiinflammatory agents, antiatherosclerotic agent
04/15/1997US5620995 Substituted heterocyclic carboxyamides, their preparation and their use as pharmaceuticals
04/15/1997US5620992 Having 5-hydroxytryptamine receptor antagonist activity
04/15/1997US5620990 Alpha-(4-chlorophenyl)-4-[(4-fluorphenyl)-methyl]piperidine-1-ethanol esters, their preparation and their therapeutic application
04/15/1997US5620989 4-Arylmethyloxymethyl piperidines as tachykinin antagonsits
04/15/1997US5620988 Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
04/15/1997US5620984 Enatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseases
04/15/1997US5620979 Treating neuronal loss associated with stroke, ischemia, central nervous system trauma, hypoglycemia or surgery
04/15/1997US5620978 Nervous system disorders
04/15/1997US5620976 Benzoxazine derivatives
04/15/1997US5620975 Pharmaceutical composition and method for the control of hypertension
04/15/1997US5620966 11,21-bisphenyl-19-norpregnane derivatives
04/15/1997US5620885 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
04/12/1997CA2187576A1 Substituted biphenylsulfonamide endothelin antagonists
04/10/1997WO1997012984A1 COMPOUND HAVING SEQUENCE HOMOLOGY WITH LIPOPROTEIN ASSOCIATED PHOSPHOLIPASE A2 (Lp-PLA2)/PAF ACETYL HYDROLASE
04/10/1997WO1997012963A2 A paf-acetylhydrolase and use in therapy
04/10/1997WO1997012902A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
04/10/1997WO1997012878A1 Amino acid derivatives, the preparation and use thereof as endothelin antagonists
04/10/1997WO1997012874A1 Imidazole derivatives having affinity for alpha2 receptors activity
04/10/1997WO1997012859A1 Succinimide and maleimide cytokine inhibitors
04/10/1997WO1997012853A1 Dimer-selective rxr modulators and methods for their use
04/10/1997WO1997012627A1 Therapeutic administration of hemoglobin in cardiac arrest
04/10/1997WO1997012625A1 Pharmaceutical angiostatic dipeptide compositions and methods of use thereof
04/10/1997WO1997012611A1 Treatment of atherosclerosis
04/10/1997WO1997005250A3 Receptor ligand vegf-c
04/10/1997DE19537548A1 Endothelin-Rezeptor-Antagonisten Endothelin receptor antagonists
04/10/1997DE19537334A1 New piperidine carboxylic acid and pyrrolidine carboxylic acid derivs.
04/10/1997DE19536891A1 Neue Aminosäurederivate, ihre Herstellung und Verwendung New amino acid derivatives, their preparation and use
04/10/1997CA2233917A1 Therapeutic administration of hemoglobin in cardiac arrest
04/10/1997CA2233888A1 Dimer-selective rxr modulators and methods for their use
04/10/1997CA2233300A1 A paf-acetylhydrolase and use in therapy
04/10/1997CA2231500A1 Novel amino acid derivatives, their preparation and use
04/10/1997CA2229434A1 Thio-substituted peptides as inhibitors for metalloproteinases and tnf liberation
04/10/1997CA2228938A1 Treatment of atherosclerosis
04/10/1997CA2187392A1 Antiadhesive piperidine-and pyrrolidinecarboxylic acids
04/09/1997EP0767170A1 Novel 4,6-diarylpyrimidine derivatives and salts thereof
04/09/1997EP0766735A1 Class bi and ci scavenger receptors
04/09/1997EP0766687A1 Phosphinic acid derivatives with metallopeptidase inhibitory activity
04/09/1997EP0766684A1 Endothelin receptor antagonists
04/09/1997EP0766667A1 Substituted azetidinone compounds useful as hypocholesterolemic agents
04/09/1997EP0766570A1 Methods for treating respiratory disease
04/09/1997EP0766558A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide
04/09/1997EP0705263B1 Novel carbocyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
04/09/1997EP0651739B1 Hydroxamic acid derivatives as metalloproteinase inhibitors
04/09/1997EP0588875B1 Microspheres useful for therapeutic vascular occlusions and injectable solutions containing the same
04/09/1997CN1147251A Tetrasubstd. imidazole derivs., method for preparing same, resulting intermediates, use thereof as drug, and pharmaceutical composition contg. same
04/09/1997CN1147250A Naphthalene derivs. as prostaglandin I2 agonists
04/09/1997CN1146992A Process for preparation of intermediate (R)-3-amino-5-methoxychroman
04/09/1997CN1034503C Pyrazolopyrimidinone antianginal agent preparing process
04/09/1997CN1034498C Octahydronaphthalene oxime derivs. for cholesterol biosynthesis inhibition, their preparation and use
04/08/1997US5618941 Benzenealkanoic acids for cardiovascular diseases
04/08/1997US5618938 Process for preparing stereo isomers of neurokinin receptor antagonists
04/08/1997US5618843 Inhibit platelet aggregation
04/08/1997US5618837 PDGF antagonists III
04/08/1997US5618833 1-benzyl-1,3-dihydroindol-2-one derivatives, their preparation and the pharmaceutical compositions in which they are present
04/08/1997US5618794 α-glycosyl derivative of catecholamine or its salt, and its preparation and uses
04/08/1997US5618792 Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
04/08/1997US5618537 Plant-based medicaments for increasing the tone and modulating the tone of the smooth muscular organ
04/08/1997US5618530 Quartenary polyallylamine
04/08/1997CA2091204C Antiischemic-piperazinyl and piperidinyl-cyclohexanes
04/03/1997WO1997012055A1 Product and process to regulate actin polymerization
04/03/1997WO1997012050A1 Method for transferring genes to the heart using aav vectors
04/03/1997WO1997012037A1 A novel haemopoietin receptor and genetic sequences encoding same
04/03/1997WO1997011960A1 Antagonists of endothelin receptors
04/03/1997WO1997011720A1 Methods for treating cancers and restenosis with p21
04/03/1997WO1997011698A1 ALPHA 1b ADRENERGIC RECEPTOR ANTAGONISTS
04/03/1997WO1997011693A1 Guanidino protease inhibitors
04/03/1997WO1997011684A1 Use of heparinases to decrease inflammatory responses
04/03/1997CA2233344A1 Guanidino protease inhibitors
04/03/1997CA2233343A1 Use of heparinases to decrease inflammatory responses